Boston Scientific Corporation (BSX) vs Stryker Corporation (SYK)
Boston Scientific Corporation and Stryker Corporation are both Medical Devices companies. Stryker Corporation is the larger, with a market value of $103.9B against $64.7B — 1.6× the size. Boston Scientific Corporation trades at the lower P/E: 17.7× against 28.0×. Boston Scientific Corporation grew revenue faster over the last twelve months: 13.5% against 8.48%. Boston Scientific Corporation has the higher net margin (17.5% vs 14.4%) and the lower return on invested capital (6.96% vs 9.76%). Across the 22 metrics below, Boston Scientific Corporation leads on 16 and Stryker Corporation on 6.
Valuation
Profitability
| Metric | BSX | SYK | Medical Devices median |
|---|---|---|---|
| Gross margin | 69.92% | 64.98% | 56.01% |
| Operating margin | 19.76% | 21.42% | (15.03%) |
| Net margin | 17.50% | 14.43% | (20.40%) |
| Free cash flow margin | 17.27% | 18.20% | (7.24%) |
| Return on equity | 15.37% | 16.51% | (15.32%) |
| Return on assets | 8.47% | 7.91% | (19.72%) |
| Return on invested capital | 6.96% | 9.76% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack